An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approach
Guan‐Qun Zhou(Sun Yat-sen University), Ying Sun(Qilu Hospital of Shandong University), Tian-Sheng Gao(Wuzhou Red Cross Hospital), Zi‐Qi Zheng(Sun Yat-sen University), Xiaodan Huang(Sun Yat-sen University), Zhao-Xi Zhang(Sun Yat-sen University), Jia Kou(Sun Yat-sen University), Jun Ma(Shanghai Jiao Tong University), Jinhui Liang(Wuzhou Red Cross Hospital), Bin Deng(Wuzhou Red Cross Hospital), Jia‐Wei Lv(Zhejiang Chinese Medical University), Fo‐Ping Chen(Sun Yat-sen University), Chen‐Fei Wu(Sun Yat-sen University), Li Lin(Sun Yat-sen University)
Cited by 47
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
|Cell Research|2020|483
Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3
|Cancer Research|2019|423
Microneedle-mediated transdermal drug delivery for treating diverse skin diseases
|Acta Biomaterialia|2020|247